Acting as a ceRNA, at least five miRNAs (e.g., miR-133a, miR-126, miR-137, miR-204-5p, and miR-329-3p) have been identified in the XIST-mediated ceRNETs that affect multiple hallmarks of glioma progression, including proliferation, apoptosis, migration, EMT, and angiogenesis (Figure 2 and Table 1). Here, XIST is linked to central nervous system cancer.